TLNC — Talon Capital Corp.

Nasdaq · Financials · Diversified Financial Services · CIK 2073340 ·
Last close
$10.29
Market Cap
$264.21M
52W High
$11.30
52W Low
$10.10
ADV30
6,982
Next earnings
Talon Capital Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Houston, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 -342,807 1,971,217 257,162,549 2,653,957 10,419,158
Sep 2025 0 -159,097 383,939 252,862,213 3,096,635 10,368,532
Jun 2025 307,810 48,000 320,067
May 2025 89,798 25,000 81,255

Balance + Analyst (yfinance extras)

Retained Earnings
$-7,093,411
Inventory
Receivables
$185,111
ST Investments
EBIT TTM
$-159,097
Pretax Income TTM
$383,939
Interest Exp TTM
Analysts

Annual Trend (SEC EDGAR, last 1y)

Revenues vs Net Income (last 1y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 255,100,876 10,328,702

Peers — same industry

TickerNameMarket CapLastDaily %
SOUL Soulpower Acquisition Corp. $264.91M $10.34
CEPV Cantor Equity Partners V, Inc. $262.68M $10.28
BLUW Blue Water Acquisition Corp. III $266.33M $10.25
CCII Cohen Circle Acquisition Corp. II $266.70M $10.25
KCHV Kochav Defense Acquisition Corp. $267.02M $10.34

News headlines (Yahoo Finance, 1h cache)

Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
2026-04-10 00:00 · Yahoo
Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
2026-01-13 01:43 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.